Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) (‘Rio Silver’ or the ‘Company’) today announced that its common shares are now trading on the U.S. OTCID Market, expanding access for United States and global investors to participate in the Company’s silver-focused growth strategy. The OTCID uplisting establishes a formal U.S. trading presence for Rio Silver and provides access to the world’s largest and most liquid capital market, enhancing visibility, accessibility, and investor engagement as the Company advances execution-driven milestones in Peru.

Additional information on Rio Silver’s U.S. OTCID listing is available at:

https://www.otcmarkets.com/stock/RYOOF/overview

Strengthening Market Access and Liquidity

The OTCID market, operated by OTC Markets Group, offers a transparent and regulated platform for U.S. investors to access securities of internationally listed companies that meet ongoing disclosure standards. With this uplisting, Rio Silver expects to benefit from improved trading efficiency, expanded investor awareness, and increased participation from U.S.-based retail and institutional investors.

This development complements the Company’s ongoing engagement initiatives, including direct investor outreach and participation in major industry conferences, as Rio Silver continues to execute its disciplined, capital-efficient development strategy.

Management Commentary

‘Uplisting to the OTCID market is a meaningful step forward for Rio Silver,’ said Chris Verrico, President and Chief Executive Officer of Rio Silver. ‘The United States represents the deepest and most active capital market globally, and this move makes it significantly easier for a broader investor audience to access our story. As we continue to advance permitting, metallurgy, and access at our projects, enhanced visibility and liquidity are important enablers as we build long-term shareholder value.’

Why This Matters to Investors

For investors, improved access matters. Trading on the OTCID market removes barriers for U.S. investors seeking exposure to silver-dominant development opportunities, while increasing transparency and market engagement. As Rio Silver advances tangible execution milestones and maintains a disciplined approach to capital allocation, expanded access to global capital supports more efficient price discovery and positions the Company to attract a wider, more diverse investor base.

About Rio Silver Inc.

Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) is a Canadian resource company advancing high-grade, silver-dominant assets in Peru, the world’s second-largest silver producer. The Company is focused on near-term development opportunities within proven mineral belts and is supported by a seasoned technical and operational team with deep experience in Peruvian geology, underground mining, and district-scale exploration. With a clear development strategy and a growing portfolio of highly prospective silver assets, Rio Silver is establishing the foundation to become one of Peru’s next emerging silver producers.

Learn more at www.riosilverinc.com

Stay Connected with Rio Silver
Investors and stakeholders are encouraged to follow Rio Silver for the latest company updates, project milestones, and event announcements across the Company’s official social media channels:

By following Rio Silver’s official channels, investors can stay informed as the Company advances its silver-dominant projects and executes on key development milestones.

ON BEHALF OF Rio Silver INC.

Chris Verrico
Director, President and Chief Executive Officer

To learn more or engage directly with the Company, please contact:
Christopher Verrico, President and CEO
Tel: (604) 762-4448
Email: chris.verrico@riosilverinc.com
Website: www.riosilverinc.com

Cautionary Note Regarding Forward-Looking Information

This news release contains ‘forward-looking statements’ within the meaning of applicable Canadian securities laws. Forward-looking statements include, but are not limited to, statements regarding anticipated development activities, underground access timing, permitting progress, community engagement, processing strategies, and the Company’s ability to advance toward potential production and cash flow. Forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on forward-looking statements. Rio Silver undertakes no obligation to update such statements except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Oreterra Metals Corp. (TSXV: OTMC) (OTCID: RMIOD) (FSE: D4R0) (WKN: A421RQ) (‘Oreterra’ or the ‘Company’) (previously, Romios Gold Resources Inc.) is pleased to announce that it intends to complete a non-brokered private placement financing for aggregate gross proceeds of up to $6,000,000 through the issuance of a combination of hard-dollar units (‘HD Units’) of the Company at a price of $0.45 per HD Unit and flow-through units (‘FT Units’) at a price of $0.50 per FT Unit (collectively, the ‘Offering’). Closing of the Offering is scheduled for March 20, 2026. The majority of the gross proceeds from the sale of both the HD Units and the FT Units will be used to carry out the first-ever drilling in the approaching field season of the large-scale Trek South porphyry copper-gold prospect located in northwestern B.C. The Trek South prospect is new to science, having been revealed by ice melt in recent years, and consists of stacked, high-order alteration, geochemical and geophysical anomalies. It is located in BC’s Golden Triangle, adjacent to Teck-Newmont’s Galore Creek deposits in ideal terrain, and close to partially completed infrastructure. A comprehensive NI 43-101 technical report on the Trek property dated January 20, 2026, can be found at www.oreterra.com and on the Company’s issuer profile at www.sedarplus.ca. An investor presentation summarizing the Trek South prospect can also be found at www.oreterra.com.

In connection with the Offering, the Company has entered into a fiscal advisory agreement with Canaccord Genuity Corp. (‘Canaccord‘). Subject to the approval of the TSX Venture Exchange (‘TSXV‘), the Company shall compensate Canaccord in the amount of $25,000, payable in HD Units of the Company (the ‘Compensation Units‘) to be issued at C$0.45 per Compensation Unit with the same terms as HD Units. In addition, 6% finder’s fees in cash or securities, or a combination of both, may be payable by Oreterra in connection with the Offering, subject to the rules of the TSXV.

Insiders may participate for up to 10% of the Offering. Such insider private placements will be exempt from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 (‘MI 61-101‘) by virtue of the exemptions contained in sections 5.5(a) and 5.7(1) (a) of MI 61-101 in that the fair market value of the consideration for the securities of the Company which will be issued to the insiders will not exceed 25% of its market capitalization.

Financing Details:

Each HD Unit, priced at $0.45, will comprise one (1) common share of the Company and one (1) common share purchase warrant (each an ‘HD Warrant‘). Each HD Warrant will entitle the holder thereof to acquire one additional common share of the Company at an exercise price of $0.60 per share for three years following the closing of the Offering.

Each FT Unit, priced at $0.50, will comprise one (1) common flow-through share of the Company (each an ‘FT Share‘), and one (1) common share purchase warrant (each an ‘FT Warrant‘). Each FT Warrant will entitle the holder thereof to acquire one additional common share of the Company at an exercise price of $0.60 per share for three years following the closing of the Offering.

The FT Shares will qualify as ‘flow-through shares’ (within the meaning of subsection 66(15) of the Income Tax Act (Canada) (the ‘Tax Act’). An amount equal to the gross proceeds from the issuance of the FT Shares will be used to incur eligible resource exploration expenses which will qualify as (i) ‘Canadian exploration expenses’ (as defined in the Tax Act), and (ii) as ‘flow-through critical mineral mining expenditures’ (as defined in subsection 127(9) of the Tax Act) (collectively, the ‘Qualifying Expenditures‘). Qualifying Expenditures in an aggregate amount not less than the gross proceeds raised from the issue of the FT Shares will be incurred (or deemed to be incurred) by the Company on or before December 31, 2027 and will be renounced by the Company to the initial purchasers of the FT Shares with an effective date no later than December 31, 2026. The net proceeds from the issuance of HD Units will be primarily used for exploration activities at the Company’s Trek property, as well as for general working capital purposes.

It is expected that the Offering will close on or about March 20, 2026, or such other date or dates that the Company may determine (the ‘Closing Date‘), subject to the receipt of all required regulatory approvals, including the approval of the TSXV. All securities issued in connection with the Offering will be subject to a hold period of four months and one day from the Closing Date, in accordance with applicable Canadian securities laws.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

Qualified Person

The technical information in this news release has been reviewed and approved by John Biczok, P.Geo., Vice President, Exploration for Oreterra and a Qualified Person as defined by National Instrument 43-101.

About Oreterra Metals Corp.

Oreterra Metals Corp. commenced trading on February 2, 2026, under the new ticker OTMC, following a months-long effort to restructure the former Romios Gold Resources Inc. Management took on the task because it believes the Company’s wholly-owned Trek South porphyry copper-gold prospect represents, based upon the impressive results of the spectrum of geosciences applied to the target area to date, among the finest new targets of its kind in BC’s Golden Triangle. The Company recently released (news, January 22, 2026) a National Instrument 43-101 Technical Report for the Trek property which recommends two initial phases of drilling at Trek South, for execution in the approaching 2026 field season. A copy of the Technical Report is available on the Company’s website at www.oreterra.com, and on the Company’s SEDAR+ issuer profile at www.sedarplus.ca.

Additional wholly-owned Company property interests include two former producers in Nevada: the Kinkaid claims in the Walker Lane trend covering numerous shallow Au-Ag-Cu workings over what is believed to be one or more porphyry centres (source: J. Biczok, P.Geo, June 2025, Kinkaid Gold-Copper-Silver Project, www.oreterra.com), and the Scossa mine property in the Sleeper trend which is a former high-grade gold producer (source: J. Biczok, P.Geo, July 2025, Scossa Historic Gold Mine Property, www.oreterra.com). The Company also holds a 100% interest in the large Lundmark-Akow Lake Au-Cu property adjacent to the northwest of the Musselwhite Mine in northwestern Ontario, where drilling by the Company has produced highly encouraging, broad VMS-style Au-Cu intersections.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward-Looking Information

This news release includes certain ‘forward-looking statements’ which are not comprised of historical facts. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as ‘believes’, ‘anticipates’, ‘expects’, ‘estimates’, ‘may’, ‘could’, ‘would’, ‘will’, or ‘plan’. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to failure to identify mineral resources, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, inability to fulfill the duty to accommodate First Nations, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry, and those risks set out in the Company’s public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

NOT FOR DISSEMINATION, DISTRIBUTION, RELEASE, OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283348

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced the publication of results from its Phase II ARCHER study in ESC Heart Failure, a journal of the European Society of Cardiology.

The peer-reviewed article reports results from a randomized, double-blind, placebo-controlled trial evaluating CardiolRx, Cardiol’s lead oral drug candidate, in 109 patients with acute myocarditis using advanced cardiac magnetic resonance (CMR) imaging measures of myocardial inflammation and remodelling.

In the study, treatment with CardiolRx produced a significant reduction in left ventricular mass versus placebo (-9.2 g; p=0.0117), along with a decrease in left atrial remodelling, and favorable trends across multiple markers of myocardial inflammation. CardiolRx was also shown to be safe and well tolerated. Reduction in left ventricular mass is widely considered consistent with decreased myocardial edema and inflammatory burden in myocarditis and improved clinical outcomes.

The biological signals observed in ARCHER are directly relevant to Cardiol’s ongoing pivotal Phase III MAVERIC trial in recurrent pericarditis. Myocarditis and pericarditis are inflammatory diseases of the myocardium and pericardium, respectively, and are recognized to fall within the spectrum of inflammatory myopericardial syndrome, an umbrella term describing the potential myocarditis-pericarditis overlap: similar causes, anatomical contiguous structures, and mixed forms with possible reciprocal involvement, such as myopericarditis and perimyocarditis.

‘This publication marks an important moment in the broader dissemination of CardiolRx’s therapeutic potential,’ said David Elsley, President and Chief Executive Officer of Cardiol Therapeutics. ‘ARCHER provides additional compelling clinical evidence that CardiolRx impacts the underlying biology of inflammatory heart disease and reduces inflammation-driven structural damage in the heart, increasing our confidence in MAVERIC, which is focused on delivering meaningful outcomes for patients with recurrent pericarditis.’

The full paper is available at:
https://academic.oup.com/eschf/advance-article/doi/10.1093/eschf/xvaf034/8427108

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. The Company’s lead small-molecule drug candidate, CardiolRx, modulates inflammasome pathway activation, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure.

The MAVERIC Program is evaluating CardiolRx for the treatment of recurrent pericarditis, an inflammatory disease of the pericardium associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, which can lead to physical limitations, reduced quality of life, emergency department visits, and hospitalizations. The program comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing pivotal Phase III MAVERIC trial (NCT06708299). The U.S. FDA has granted Orphan Drug Designation to CardiolRx for the treatment of pericarditis, including recurrent pericarditis.

The ARCHER Program is also studying CardiolRx, specifically in acute myocarditis-an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in individuals under 35 years of age. The program comprises the completed Phase II ARCHER study (NCT05180240), which evaluated the safety, tolerability, and efficacy of CardiolRx in this patient population.

The Company is also developing CRD-38, a novel, subcutaneously administered drug formulation intended for the treatment of inflammatory heart disease, including heart failure-a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding US$30 billion per year.

For more information about Cardiol Therapeutics, please visit cardiolrx.com.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward looking information contained herein may include, but is not limited to statements regarding the Company’s focus on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, the Company’s intended clinical studies and trial activities and timelines associated with such activities, including the Company’s plan to complete the Phase III study in recurrent pericarditis with CardiolRx, the Company’s plan to advance the development of CRD-38, a novel subcutaneous formulation intended for the treatment of inflammatory heart disease, including heart failure, including through the initiation of the first-in-human clinical evaluation, and the Company’s belief that results from the ARCHER trial provide compelling clinical proof of concept for CardiolRx, strengthen the scientific and clinical rationale for Cardiol’s lead Phase III program in recurrent pericarditis. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Information Form filed with the Canadian securities administrators and U.S. Securities and Exchange Commission on March 31, 2025, available on SEDAR+ at sedarplus.ca and EDGAR at sec.gov, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283346

Sranan Gold Corp. (CSE: SRAN) (OTCQB: SRANF) (FSE: P84) (Tradegate: P84) (‘Sranan’ or the ‘Company’) is pleased to announce that it has entered into an option agreement (the ‘Agreement’) with Lawantino N.V. (the ‘Vendor’) to acquire up to a 100% interest in the 18,468-hectare Lawantino Gold Property (the ‘Property’) situated in southeastern Suriname. The acquisition of the Property, which is currently the focus of extensive artisanal alluvial mining (see Figure 1), strengthens Sranan’s position within the highly prospective Guiana Shield, a region recognized for structurally controlled gold mineralization. The Company now controls 47,500 hectares of high-potential land for exploration.

The Property is strategically located along the same deep-seated regional structure, the Central Guiana Shear Zone (CGSZ), that hosts Founders Metals’ Antino Gold Project and Miata Metals’ Sela Creek Project, two of the most active gold exploration projects in Suriname.

The Company has confirmed the presence of extensive active artisanal alluvial mining (see Figure 2) with multiple generations of mining (miners return to the same sites with more effective equipment). Sampling of limited saprolite exposure encountered shear-hosted quartz veins cutting granite near the contact with basaltic rocks. Two samples returned 4.24 and 1.88 grams per tonne gold, which are considered significant given the limited evaluation completed.

Oscar Louzada, Sranan’s CEO, stated: ‘The Lawantino acquisition is a strategic addition to our Suriname exploration portfolio, strengthening our position along a proven and highly prospective structural corridor. The Project benefits from favourable geology, clear evidence of gold endowment through ongoing artisanal mining, and proximity to two active gold exploration projects. Lawantino fits well with our disciplined growth strategy and complements our ongoing work at Tapanahony as we continue to build value through systematic exploration.’

Sranan’s initial exploration program will focus on integrating areas of artisanal mining with satellite interpretation, geological mapping, geochemical sampling, and structural analysis to prioritize targets for future trenching and drilling. The approach is to develop targets quickly and efficiently. A variety of lithologies observed in mine workings, including basalt, siltstone, and other metasediments, suggest a variety of potentially favourable lithologies and structures to test.

Auracle Geospatial Science Inc. (‘Auracle’) was contracted by Sranan to analyze the structural complexity of the Lawantino Property by means of its proprietary Mapped Underworld Dimension (MUD® SAR) remote-sensing system. Results from Auracle’s analysis show a distinct increase in fracture density in association with abundant small-scale miners (see Figure 3). A similar increase in fracture density is observed on the east portion of the Lawantino Property.

Lawantino Agreement Terms

Pursuant to the terms of the Agreement, dated February 5, 2026, Sranan may earn a 100% interest in the Property by making cash and share payments and completing exploration-related expenditures. Over a 5-year period, the Company may earn 90% interest in the Property by making total cash payments of US$1,900,000, issuing 1,800,000 common shares to the arm’s-length Vendor, and completing exploration expenditures on the Property totaling US$1,700,000. Upon completion of the 90% earn-in, the Vendor will retain a 10% interest in the Property and a 2% net smelter return royalty (‘NSR’) on all metals production from the Property. There was no finder fees paid.

Sranan may repurchase the 2% NSR for US$3.0 million and, upon the establishment of a minimum 750,000-ounce measured and indicated gold resource, may acquire the remaining 10% interest in the Property based on an independent valuation.

Table 1: Summary of Lawantino Property Agreement Earn-in Obligations

Figure 1. Location of the Lawantino Property, along the CGSZ, showing major drainages and areas of small-scale mining.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/283308_94a3d6ef64bd5aaa_001full.jpg

Figure 2. Scouting flight showing extensive, active alluvial mining (December 23, 2025)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/283308_94a3d6ef64bd5aaa_002full.jpg

Figure 3. Fracture Density Image generated by Auracle using MUD® SAR. Red areas indicate more intense ground preparation favourable for gold. Active areas of small-scale mining in bright yellow. The CGSZ cuts southeast to northwest through the concession.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/283308_94a3d6ef64bd5aaa_003full.jpg

Dr. Dennis LaPoint, EVP of Exploration and Business Development, states, ‘I am very excited about this new acquisition along the same structural trend of the CGSZ that hosts two active gold exploration projects. Lawantino complements our ongoing drilling program at our Tapanahony Gold Project and demonstrates that Sranan will continue to expand our portfolio of gold projects based on our extensive knowledge of Suriname. The agreement with Lawantino N.V. represents a major step in expanding our footprint within Suriname’s highly prospective southeastern part of the Marowijne greenstone belt along one of the major controlling structures for large gold deposits. A strength of the Sranan team is our ability to develop early-stage projects into potential new discoveries. I first reviewed this area in 2007 when held by Canarc, so I am very pleased with our cooperation and relationship with Lawantino shareholders.’

Samples were prepared and assayed by Filab in Paramaribo, Suriname. All samples >2 g/t Au were re-assayed with 50-gram re-assay and gravimetric assay. Standard QA/QC procedures were followed and showed a satisfactory level of reproducibility. The Company notes that the drill intercepts may not represent true underlying mineralization. Core logging, photography, and sampling are completed under strict industry standard QA/QC protocols (Oreas certified reference materials, assayed coarse blanks, duplicates of core).

Qualified Person

Dr. Dennis J. LaPoint, Ph.D., P.Geo., a ‘qualified person’ as defined under National Instrument 43-101, has reviewed and approved the scientific and technical information contained in this release. Dr. LaPoint is not independent of Sranan Gold, as he is the Company’s EVP of Exploration and Corporate Development.

About Sranan Gold Corp.

Sranan is engaged in the business of mineral exploration and the acquisition of mineral property assets in Suriname. The Company’s flagship Tapanahony Project covers 29,000 hectares in one of Suriname’s most prolific artisanal gold mining districts.

For more information, please visit www.sranangold.com.

THE CANADIAN SECURITIES EXCHANGE HAS NOT APPROVED NOR DISAPPROVED THE CONTENT OF THIS PRESS RELEASE.

Forward-looking Statements

Certain statements in this release constitute ‘forward-looking statements’ or ‘forward-looking information’ within the meaning of applicable securities laws, including, without limitation, the successful completion of the acquisition of the Lawantino Gold Project as discussed in this press release, the timing, nature, scope and details regarding the Company’s exploration plans and results at its projects. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, its projects, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as ‘may’, ‘would’, ‘could’, ‘will’, ‘intend’, ‘expect’, ‘believe’, ‘plan’, ‘anticipate’, ‘estimate’, ‘scheduled’, ‘forecast’, ‘predict’ and other similar terminology, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved. These statements reflect the Company’s current expectations regarding future events, performance and results and speak only as of the date of this release. Further details about the risks applicable to the Company are contained in the Company’s public filings available on SEDAR+ (www.sedarplus.ca), under the Company’s profile.

Forward-looking statements and information contained herein are based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and reserves, the realization of resource and reserve estimates, metal prices, taxation, the estimation, timing and amount of future exploration and development, capital and operating costs, the availability of financing, the receipt of regulatory approvals, environmental risks, title disputes and other matters. While the Company considers its assumptions to be reasonable as of the date hereof, forward-looking statements and information are not guarantees of future performance and readers should not place undue importance on such statements as actual events and results may differ materially from those described herein. The Company does not undertake to update any forward-looking statements or information except as may be required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283308

Relationship Represents Potential Long Term Scalability of High Efficiency Supply Chain from Demonstration to Commercial Scale

Syntholene Energy CORP (TSXV: ESAF) (FSE: 3DD0) (OTCQB: SYNTF) (‘Syntholene’ or the ‘Company’) announces that it has selected Dynelectro ApS (Denmark) as the electrolyzer technology vendor for its planned synthetic fuel demonstration facility in Iceland. Dynelectro is the developer of what it describes as the world’s most efficient electrolyzer platform, purpose-built for high-performance hydrogen production in power-to-liquids applications for synthetic fuel (‘eFuel’) and, more specifically, synthetic sustainable aviation fuel (‘eSAF’).

Dynelectro’s electrolyzer platform has demonstrated industry-leading energy efficiency in the production of hydrogen, a key feedstock to eFuels, while maintaining durability under continuous industrial operation at variable load. The system architecture emphasizes reduced balance-of-plant complexity, high current density operation, and modular deployment, characteristics that align closely with Syntholene’s objective of developing capital-efficient, repeatable synthetic fuel infrastructure.

The planned demonstration facility is intended to validate the Company’s integrated approach to producing low-cost hydrogen as a feedstock to eSAF and other eFuels, with a focus on scalability, energy efficiency, and long-term cost competitiveness with fossil fuels.

‘Syntholene’s eSAF production plans are a perfect match for Dynelectro’s electrolyser solution,’ explains Sune Lilbaek, CEO at Dynelectro ApS. ‘To be successful in the eSAF market, the lowest possible cost of hydrogen over the lifespan of the plant is a necessity. Dynelectro’s unique take on SOEC electrolysers seeks to enable the lowest possible energy consumption and maintenance cost. When integrated with Syntholene’s proprietary hybrid thermal production system, it is possible to convert up to 90% of the renewable electrical energy supplied into clean hydrogen. Together, we expect to be deploying the most cost-effective, energy-efficient solution for production of sustainable aviation fuel on the market today.’

The vendor selection represents a key technical milestone for Syntholene as it advances engineering and procurement activities associated with its first demonstration-scale facility.

‘The selection of Dynelectro is the result of a rigorous two-year technical and commercial evaluation process across all major vendors focused on efficiency, reliability, and long-term scalability,’ said Dan Sutton, CEO of Syntholene. ‘Electrolyzer performance coupled with low-cost clean energy are the primary drivers of synthetic fuel economics. Partnering with a technology provider that prioritizes energy efficiency and industrial robustness is critical as we move from demonstration toward multi-megawatt commercial deployment.’

About Syntholene

Syntholene is actively commercializing its novel Hybrid Thermal Production System for low-cost clean fuel synthesis. The target output is ultrapure synthetic jet fuel, manufactured at 70% lower cost than the nearest competing technology today. The company’s mission is to deliver the world’s first truly high-performance, low-cost, and carbon-neutral synthetic fuel at an industrial scale, unlocking the potential to produce clean synthetic fuel at lower cost than fossil fuels, for the first time.

Syntholene’s power-to-liquid strategy harnesses thermal energy to power proprietary integrations of hydrogen production and fuel synthesis. Syntholene has secured 20MW of dedicated energy to support the Company’s upcoming demonstration facility and commercial scale-up.

Founded by experienced operators across advanced energy infrastructure, nuclear technology, low-emissions steel refining, process engineering, and capital markets, Syntholene aims to be the first team to deliver a scalable modular production platform for cost-competitive synthetic fuel, thus accelerating the commercialization of carbon-neutral eFuels across global markets.

About Dynelectro

Dynelectro is a Danish SOE electrolyser OEM at the forefront of developing advanced, sustainable energy solutions. Utilising cutting-edge solid-oxide electrolysis technology, Dynelectro achieves unprecedented system performance and lifespan, enabling a five-fold improvement in lifetime performance through a novel approach to stack control and integration. Their innovations enable operators to seamlessly adjust production based on the availability of cost-effective renewable energy.

The company commercialises MW-scale Dynamic Electrolyser Units (DEUs), producing clean hydrogen to unlock syngas and e-fuel production. Dynelectro was founded in 2018 and is headquartered in the capital region of Denmark. Visit www.dynelectro.dk

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. The use of any of the words ‘expect’, ‘anticipate’, ‘aims’, ‘continue’, ‘estimate’, ‘objective’, ‘may’, ‘will’, ‘project’, ‘should’, ‘believe’, ‘plans’, ‘intends’ and similar expressions are intended to identify forward-looking information or statements. All statements, other than statements of historical fact, including but not limited to statements regarding the use of a particular vendor, the services to be provided and standard of delivery, expected benefits of engagement of certain service providers, development of the Company’s test facility, commercial scalability, technical and economic viability, anticipated geothermal power availability, anticipated benefit of eFuel, the Company’s business plans, and future commercial opportunities, are forward-looking statements.

The forward-looking statements and information are based on certain key expectations and assumptions made by the Company, including without limitation the assumption that the Company will be able to execute its business plan, that the eFuel will have its expected benefits, that the selected vendor will be able to complete their deliverables on time and to the standard expected, that the test facility will be completed as planned, that there will be market adoption, and that the Company will be able to access financing as needed to fund its business plan. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

Actual results could differ materially from those currently anticipated due to a number of factors and risks, including, without limitation, Syntholene’s ability to meet production targets, realize projected economic benefits, meet targeted timelines for development, overcome technical challenges, secure financing, maintain regulatory compliance, manage geopolitical risks, and successfully negotiate definitive terms. Syntholene does not undertake any obligation to update or revise these forward-looking statements, except as required by applicable securities laws.

Readers are advised to exercise caution and not to place undue reliance on these forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283350